Strong patent protection limits access to HIV/AIDS drugs in developing countries where over five million people are in immediate need of these drugs. This comment summarizes the history of HIV/AIDS drugs and international patent law, how laws affect distribution of the drugs, and concludes by discussing public and private partnerships which could afford more access in developing countries.
Profitability versus the Public Interest: Is International Patent Law Hindering Third World Countries Access to HIV/AIDS Medications,
Rich. J. L. & Pub. Int.
Available at: http://scholarship.richmond.edu/pilr/vol10/iss2/5